Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Current Assets (2023 - 2025)

Historic Current Assets for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $189.8 million.

  • Metagenomi's Current Assets fell 3275.78% to $189.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.8 million, marking a year-over-year decrease of 3275.78%. This contributed to the annual value of $258.0 million for FY2024, which is 729.97% down from last year.
  • Metagenomi's Current Assets amounted to $189.8 million in Q3 2025, which was down 3275.78% from $211.7 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Current Assets ranged from a high of $335.6 million in Q1 2024 and a low of $189.8 million during Q3 2025
  • Moreover, its 3-year median value for Current Assets was $268.1 million (2023), whereas its average is $262.1 million.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 729.97% in 2024, then plummeted by 3275.78% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Current Assets stood at $278.3 million in 2023, then decreased by 7.3% to $258.0 million in 2024, then dropped by 26.41% to $189.8 million in 2025.
  • Its Current Assets stands at $189.8 million for Q3 2025, versus $211.7 million for Q2 2025 and $233.2 million for Q1 2025.